Stevanato Group S.p.A. - SIC # 3850 -

Ticker Exchange SIC # Website Latest Ticker
STVN New York 3850 www.stevanatogroup.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Stevanato Group S.p.A.

Stevanato Group to Participate in Two Upcoming Investor Conferences - Sep 8th, 2026 2:05 pm
Stevanato Group (STVN) Trades A Subsidiary For Margin Gains And Growth - Sep 4th, 2026 6:01 am
Riverwater Sees a Market Overreaction in Stevanato Group (STVN) After Oral GLP-1 Launches - Sep 1st, 2026 6:50 am
Stevanato Group (STVN) Could Be 16% Undervalued Following Earnings And Guidance Update - Aug 10th, 2026 8:08 pm
How Investors Are Reacting To Stevanato Group (STVN) Trimmed Guidance And New GLP-1 Pen Approvals - Aug 10th, 2026 7:12 am
Stevanato Group (STVN) Stock Looks Cheap On Cash Flow But Pricey On Earnings - Aug 10th, 2026 5:11 am
Stevanato Group Q2 Earnings Call Highlights - Aug 9th, 2026 2:03 am
Is Stevanato (STVN) a Solid Growth Stock? 3 Reasons to Think "Yes" - Aug 5th, 2026 10:45 am
Stevanato (STVN) Q2 2026 Earnings Call Transcript - Aug 4th, 2026 8:41 pm
Stevanato Group S.p.A. Q2 2026 Earnings Call Summary - Aug 4th, 2026 7:38 pm
Stevanato Group SpA (STVN) (Q2 2026) Earnings Call Highlights: Biologics Surge and Alina ... - Aug 4th, 2026 3:02 pm
Sage Park Acquires Balda C. Brewer, the California-based Contract Manufacturing Injection Molding Subsidiary From Stevanato Group S.p.A. - Aug 4th, 2026 8:00 am
Stevanato Group (STVN) Q2 Earnings Top Estimates - Aug 4th, 2026 5:50 am
Stevanato Group Delivers 8% Revenue Growth for the Second Quarter of Fiscal 2026 - Aug 4th, 2026 4:30 am
Liraglutide Combination Products Incorporating Stevanato Group's Alina® Pen Injector Received Marketing Authorizations in Multiple European Countries - Jul 30th, 2026 4:30 am
Ionis Pharmaceuticals (IONS) Reports Q2 Loss, Tops Revenue Estimates - Jul 29th, 2026 6:25 am
Stevanato Group to Report Second Quarter 2026 Financial Results on August 4, 2026 - Jul 21st, 2026 4:30 am
Profound Medical (PROF) Moves 8.2% Higher: Will This Strength Last? - Jul 7th, 2026 5:38 am